Liraglutide improves weight loss in people who are overweight or obese, study shows
BMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h3545 (Published 02 July 2015) Cite this as: BMJ 2015;351:h3545- Susan Mayor
- 1London
Liraglutide significantly reduces body weight and improves metabolic control in people who are obese or overweight and have dyslipidaemia or hypertension, a randomised trial reported in the New England Journal of Medicine has shown.1
The study randomised 3731 people who were obese, had a body mass index (BMI) of at least 30, or were overweight (BMI>27), and who had treated or untreated dyslipidaemia or hypertension, to treatment with once daily injections of liraglutide (3.0 mg) or placebo in addition to counselling on lifestyle changes.
Liraglutide …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.